Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2

29Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Author supplied keywords

Cite

CITATION STYLE

APA

Martin-Blondel, G., Marcelin, A. G., Soulié, C., Kaisaridi, S., Lusivika-Nzinga, C., Dorival, C., … Yordanov, Y. (2022, October 1). Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2. Journal of Infection. W.B. Saunders Ltd. https://doi.org/10.1016/j.jinf.2022.06.033

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free